WCM
PFE icon

Wisconsin Capital Management’s Pfizer PFE Stock Holding History

Wisconsin Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-22,725
Closed -$837K – 59
2020
Q4 		$837K Buy
22,725
+16,348
+256% +$600K 0.32% 41
2020
Q3 		$222K Buy
+6,377
New +$224K 0.1% 46
2014
Q4 		$209K Buy
+7,076
New +$203K 0.07% 124
2014
Q2 		– Sell
-6,601
Closed -$201K – 118
2014
Q1 		$201K Buy
+6,601
New +$197K 0.08% 110

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wisconsin Capital Management's PFE Position: Q1 2021 in Review

Wisconsin Capital Management sold out of Pfizer (PFE) in Q1 2021, closing a stake of 22,725 shares — an estimated $837K sold.

Wisconsin Capital Management first reported a position in PFE in Q1 2014 and held it in 4 quarters. The position peaked at $837K in Q4 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Wisconsin Capital Management reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Wisconsin Capital Management sold 22,725 Pfizer shares in Q1 2021, an estimated $837K.
  • Wisconsin Capital Management first reported a position in Pfizer in Q1 2014 and held it in 4 quarters.
  • Wisconsin Capital Management's Pfizer position peaked at $837K in Q4 2020.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Wisconsin Capital Management's 13F filing for Q1 2021, filed 3 May 2021.